Jamie Goldstein
Founder and Partner @ Pillar VC
Boston, United States
Jamie Goldstein is a seed investor at Pillar VC in Boston focused on Artificial Intelligence and Software. Jamie Goldstein is the Founding Partner of Pillar VC. He previously worked at LBRY as a Board Member and Investor. Jamie Goldstein attended Massachusetts Institute of Technology.
- Total investments:
- 72
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Jamie Goldstein invests in
Stages Jamie Goldstein invests in
Countries Jamie Goldstein invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $500k–$10M
- Series A
- $6M–$36M
- Series B
- $5M–$175M
Investment Focus
Industry
- Artificial Intelligence 10 (14%)
- Software 8 (11%)
- Health Care 7 (10%)
- Biotechnology 7 (10%)
- Information Technology 7 (10%)
Stage
- Seed 22 (31%)
- Series A 12 (17%)
- Series B 9 (13%)
- Series C 6 (8%)
- Funding Round 4 (6%)
Country
- United States 35 (49%)
- United Kingdom 1 (1%)
- The Netherlands 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production. | $8.3M / Seed / Dec 01, 2025 | ||
| Matterworks is a biotech startup that combines metabolomics with AI to simulate the metabolic environment. The startup is enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics.Matterworks was founded by Mimoun Cadosch Delmar and JackGeremia in 2019. | Series A / Jun 03, 2025 | ||
| LightSource develops a supply chain management platform to help professionals collaborate with their suppliers. It also allows collaborating with teammates on strategic sourcing projects, sending RFQs to suppliers and collecting quotes, and comparing bids using insights automatically extracted from the normal day-to-day work.The company wasfounded in 2021 and is headquartered in San Francisco, California. | $33M / Series A / Mar 31, 2025 | ||
| VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping dentists avoid missing diseases and effectively communicating treatment recommendations to patients. Today, dentists miss up to 50% of pathologies in dental x-rays. Treatment delays or non-treatment often results in significant health risks forthe patient and a loss of revenue for the dentists as he cannot treat missed diseases. | $40M / Series B / Jan 28, 2025 | ||
| Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production. | $4.3M / Pre-Seed / Jan 21, 2025 | ||
| Adaptilens develop an accommodating intraocular lens. Adaptilen's mission is to bring to market an accommodative intraocular lens that mimics the natural human lens so that patients will have excellent near and distance vision without eyeglasses or contact lenses. | $17.5M / Series A / Apr 29, 2024 | ||
| Asimov creates tools for programming living cells. Its multidisciplinary team is advancing the design and manufacture of biologics and gene therapies by integrating mammalian synthetic biology, computer-aided design, and machine learning. Asimov was established in 2017 by Raja Srinivas in Boston, Massachusetts. | $175M / Series B / Jan 05, 2023 | ||
| Abridge provides an AI platform that transforms patient-clinician conversations into structured, billable clinical notes. This technology aims to reduce documentation burdens for clinicians and nurses. The system integrates into existing healthcare workflows and electronic health record systems. | $12.5M / Series A / Aug 11, 2022 | ||
| You ask the questions, the world’s top experts share their answers. | Seed / Apr 01, 2022 | ||
| VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping dentists avoid missing diseases and effectively communicating treatment recommendations to patients. Today, dentists miss up to 50% of pathologies in dental x-rays. Treatment delays or non-treatment often results in significant health risks forthe patient and a loss of revenue for the dentists as he cannot treat missed diseases. | $20M / Series A / Mar 31, 2022 | ||
| See all 72 investments → | |||
Co-Investors
About Pillar VC
Pillar VC is an early-stage Boston-based venture firm. Pillar VC is a seed stage fund purpose built to spin frontier companies out of research labs. We have perfected our lab to launch playbook, successfully repeating it over 50 times to produce category leading companies. Pillar partners at inception with founders building healthcare companies that are improving patient outcomes like Abridge, Videa Health, and PathAI; computing and enterprise intelligence, like Cimulate, Jellyfish, and Neural Magic; new approaches to scientific discovery like Edison, Latent Labs and Asimov. Our team manages $500M in assets with an active $175M Fund IV; our investments span over 90 companies, 50% with university roots, and we have a strong performance track record.
Pillar VC Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Parker McKee
Partner
|
|||
Ash Ashutosh
Co-founder
|
|||
Emily Batt
Senior Associate
|
|||
|
Jamie Goldstein
Founder and Partner
|
|||
Jeremy Hitchcock
Pillar VC Founding Pillar
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jamie Goldstein invest in?
Jamie Goldstein invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Seed and Series A stage. Most of the 72 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Jamie Goldstein invest in?
Jamie Goldstein typically joins rounds of $500k–$10M at Seed, $6M–$36M at Series A and $5M–$175M at Series B. These are whole funding-round sizes, not Jamie Goldstein's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Jamie Goldstein took part in.
How do I contact Jamie Goldstein?
Public channels for Jamie Goldstein include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jamie Goldstein last invest?
The most recent investment recorded for Jamie Goldstein closed in Dec 2025. Shizune tracks 72 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
